186 related articles for article (PubMed ID: 32058103)
1. Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.
Pietsch M; Viht K; Schnitzler A; Ekambaram R; Steinkrüger M; Enkvist E; Nienberg C; Nickelsen A; Lauwers M; Jose J; Uri A; Niefind K
Bioorg Chem; 2020 Mar; 96():103608. PubMed ID: 32058103
[TBL] [Abstract][Full Text] [Related]
2. The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven.
Raaf J; Brunstein E; Issinger OG; Niefind K
Protein Sci; 2008 Dec; 17(12):2180-6. PubMed ID: 18824508
[TBL] [Abstract][Full Text] [Related]
3. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies.
Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A
Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938
[TBL] [Abstract][Full Text] [Related]
4. First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligand.
Raaf J; Guerra B; Neundorf I; Bopp B; Issinger OG; Jose J; Pietsch M; Niefind K
ACS Chem Biol; 2013 May; 8(5):901-7. PubMed ID: 23474121
[TBL] [Abstract][Full Text] [Related]
5. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of Tetracyclic Inhibitors of Protein Kinase CK2 Derived from Furocarbazole W16.
Kröger L; Daniliuc CG; Ensan D; Borgert S; Nienberg C; Lauwers M; Steinkrüger M; Jose J; Pietsch M; Wünsch B
ChemMedChem; 2020 May; 15(10):871-881. PubMed ID: 32168422
[TBL] [Abstract][Full Text] [Related]
7. Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction.
Hochscherf J; Lindenblatt D; Steinkrüger M; Yoo E; Ulucan Ö; Herzig S; Issinger OG; Helms V; Götz C; Neundorf I; Niefind K; Pietsch M
Anal Biochem; 2015 Jan; 468():4-14. PubMed ID: 25233003
[TBL] [Abstract][Full Text] [Related]
8. Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.
Kufareva I; Bestgen B; Brear P; Prudent R; Laudet B; Moucadel V; Ettaoussi M; Sautel CF; Krimm I; Engel M; Filhol O; Borgne ML; Lomberget T; Cochet C; Abagyan R
Sci Rep; 2019 Nov; 9(1):15893. PubMed ID: 31685885
[TBL] [Abstract][Full Text] [Related]
9. CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.
Janeczko M; Orzeszko A; Kazimierczuk Z; Szyszka R; Baier A
Eur J Med Chem; 2012 Jan; 47(1):345-50. PubMed ID: 22115617
[TBL] [Abstract][Full Text] [Related]
10. The protein kinase CK2(Andante) holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation.
Schnitzler A; Olsen BB; Issinger OG; Niefind K
J Mol Biol; 2014 May; 426(9):1871-82. PubMed ID: 24594356
[TBL] [Abstract][Full Text] [Related]
11. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
Raaf J; Issinger OG; Niefind K
J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
Laudet B; Barette C; Dulery V; Renaudet O; Dumy P; Metz A; Prudent R; Deshiere A; Dideberg O; Filhol O; Cochet C
Biochem J; 2007 Dec; 408(3):363-73. PubMed ID: 17714077
[TBL] [Abstract][Full Text] [Related]
13. Design of CK2β-Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells.
Lindenblatt D; Horn M; Götz C; Niefind K; Neundorf I; Pietsch M
ChemMedChem; 2019 Apr; 14(8):833-841. PubMed ID: 30786177
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase CK2 in health and disease: Protein kinase CK2: from structures to insights.
Niefind K; Raaf J; Issinger OG
Cell Mol Life Sci; 2009 Jun; 66(11-12):1800-16. PubMed ID: 19387553
[TBL] [Abstract][Full Text] [Related]
15. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
[TBL] [Abstract][Full Text] [Related]
16. Primary and secondary interactions between CK2alpha and CK2beta lead to ring-like structures in the crystals of the CK2 holoenzyme.
Niefind K; Issinger OG
Mol Cell Biochem; 2005 Jun; 274(1-2):3-14. PubMed ID: 16335523
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.
Ermakova I; Boldyreff B; Issinger OG; Niefind K
J Mol Biol; 2003 Jul; 330(5):925-34. PubMed ID: 12860116
[TBL] [Abstract][Full Text] [Related]
18. Role of plant-specific N-terminal domain of maize CK2β1 subunit in CK2β functions and holoenzyme regulation.
Riera M; Irar S; Vélez-Bermúdez IC; Carretero-Paulet L; Lumbreras V; Pagès M
PLoS One; 2011; 6(7):e21909. PubMed ID: 21789193
[TBL] [Abstract][Full Text] [Related]
19. Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface.
Raaf J; Bischoff N; Klopffleisch K; Brunstein E; Olsen BB; Vilk G; Litchfield DW; Issinger OG; Niefind K
Biochemistry; 2011 Feb; 50(4):512-22. PubMed ID: 21142136
[TBL] [Abstract][Full Text] [Related]
20. Structure of human protein kinase CK2 alpha 2 with a potent indazole-derivative inhibitor.
Nakaniwa T; Kinoshita T; Sekiguchi Y; Tada T; Nakanishi I; Kitaura K; Suzuki Y; Ohno H; Hirasawa A; Tsujimoto G
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):75-9. PubMed ID: 19193990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
